HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-stearoylethanolamine

Networked: 23 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Amino Alcohols: 20
    - Ethanolamines: 16
      - N-stearoylethanolamine: 23
- Alcohols: 595
  - Ethanol: 23169
    - Ethanolamines: 16
      - N-stearoylethanolamine: 23
  - Amino Alcohols: 20
    - Ethanolamines: 16
      - N-stearoylethanolamine: 23
Lipids: 114793
- Fatty Acids: 27405
  - Stearic Acids: 44
    - N-stearoylethanolamine: 23

Experts

1.	Hula, N M: 14 articles (01/2015 - 01/2006)
2.	Horid'ko, T M: 9 articles (05/2014 - 01/2008)
3.	Berdyshev, A H: 8 articles (05/2014 - 09/2007)
4.	Kosiakova, H V: 7 articles (05/2014 - 09/2007)
5.	Mehed', O F: 5 articles (05/2014 - 01/2008)
6.	Kindruk, N L: 5 articles (07/2011 - 01/2008)
7.	Onopchenko, O V: 4 articles (01/2015 - 09/2013)
8.	Klimashevs'kyĭ, V M: 4 articles (05/2014 - 01/2006)
9.	Chumak, A A: 4 articles (07/2011 - 01/2008)
10.	Khmel', T O: 3 articles (07/2012 - 01/2006)

Related Diseases

1.	Obesity 01/01/2014 - "[The effect of N-stearoylethanolamine on liver phospholipid composition of rats with insulin resistance caused by alimentary obesity]." 01/01/2021 - "The aim: To determine the set of structural and functional changes in pancreatic islets (PI) of obesity-induced insulin resistant (IR) rats of different age (young and old) fed with prolonged (6 month) high-fat diet (HFD) (58% of fat) and further treatment with N-Stearoylethanolamine (NSE), a bioactive N-Acylethanolamine. " 01/01/2015 - "N-stearoylethanolamine restores pancreas lipid composition in obesity-induced insulin resistant rats." 11/01/2014 - "The effect of N-stearoylethanolamine on cholesterol content, fatty acid composition and protein carbonylation level in rats with alimentary obesity-induced insulin resistance." 01/01/2014 - "We used alimentary obesity-induced insulin resistance (IR) model in rats to investigate the influence of N-stearoylethanolamine on the content of phospholipids and their fatty acid composition. "
2.	Body Weight (Weight, Body) 03/01/2010 - "N-stearoylethanolamine (NSE) in a dose of 50 mg/kg of body weight shows the pronounced antioxidative and hepatoprotective properties under these conditions. " 11/01/2009 - "It was shown for the first time that endogenous cannabimimetic compound N-stearoylethanolamine (NSE) administered at the dose 65 mg/kg of body weight during two weeks before anaphylaxis had cardioprotective properties on the model of anaphylactic shock in the guinea pigs. " 09/01/2007 - "The aim of the presented experiments was to study the influence of suturated NAE--N-stearoylethanolamine (NSE) on the NO synthesis by NO-synthases in aorta and heart tissues of rats with developmental (12-week) streptozotocin-induced (50 mg/kg of body weight) diabetes. " 05/01/2010 - "The influence of N-stearoylethanolamine (NSE) on total 11-hydroxycorticosteroids (11-HCS) and testosterone level in the blood of male rats in normal conditions and under the action of 17beta-estradiol (400 mkg/kg of body weight during 3 days) was studied. "
3.	Neoplasms (Cancer) 03/03/2023 - "This study reports a dose-dependent pro-apoptotic action of synthetic cannabimimetic N-stearoylethanolamine (NSE) on diverse cancer cell lines, including multidrug-resistant models. " 01/01/2006 - "We investigated the influence of N-stearoylethanolamine (NSE) on tumor growth and metastasis of the lung Lewis carcinoma in mice. " 03/03/2023 - "Cannabimimetic N-Stearoylethanolamine as "Double-Edged Sword" in Anticancer Chemotherapy: Proapoptotic Effect on Tumor Cells and Suppression of Tumor Growth versus Its Bio-Protective Actions in Complex with Polymeric Carrier on General Toxicity of Doxorubicin In Vivo."
4.	Insulin Resistance 01/01/2015 - "The effect of N-stearoylethanolamine on plasma lipid composition in rats with experimental insulin resistance." 01/01/2014 - "[The effect of N-stearoylethanolamine on liver phospholipid composition of rats with insulin resistance caused by alimentary obesity]." 11/01/2014 - "The effect of N-stearoylethanolamine on cholesterol content, fatty acid composition and protein carbonylation level in rats with alimentary obesity-induced insulin resistance." 01/01/2014 - "We used alimentary obesity-induced insulin resistance (IR) model in rats to investigate the influence of N-stearoylethanolamine on the content of phospholipids and their fatty acid composition. " 09/01/2013 - "The influence of N-stearoylethanolamine (NSE) on the content of lipid peroxidation products, activity of antioxidant enzymes and the nitric oxide level in the liver and blood plasma of rats with insulin-resistance (IR) state was investigated. "
5.	Carcinoma (Carcinomatosis) 03/01/2013 - "[Organ-specific antitoxic effects of N-stearoylethanolamine in male mice with Lewis carcinoma under doxorubicin intoxication]." 01/01/2006 - "We investigated the influence of N-stearoylethanolamine (NSE) on tumor growth and metastasis of the lung Lewis carcinoma in mice. " 03/01/2006 - "[The effect of N-stearoylethanolamine on lipid composition of the metastases and conditionally normal lung tissue in mice with Lewis carcinoma]." 01/01/2006 - "[N-stearoylethanolamine inhibits growth and metastasis of the Lewis carcinoma and modulates lipid composition of the lung during tumorogenesis in mice]." 07/01/2012 - "N-stearoylethanolamine, both in the nanocomplex and in suspension, modulates activity of enzymes of antioxidantive protection of the heart, kidney and liver tissue of mice with the Lewis carcinoma."

Related Drugs and Biologics

1.	Lipids
2.	N-acylethanolamines
3.	Streptozocin (Streptozotocin)
4.	Insulin (Novolin)
5.	Enzymes
6.	Doxorubicin (Adriamycin)
7.	Antioxidants
8.	Cytokines
9.	11-Hydroxycorticosteroids
10.	Nitric Oxide (Nitrogen Monoxide)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)